Latest Breaking News On - Spyre therapeutics - Page 8 : comparemela.com

Stifel Nicolaus Boosts Spyre Therapeutics (NASDAQ:SYRE) Price Target to $54.00

Spyre Therapeutics (NASDAQ:SYRE – Free Report) had its target price hoisted by Stifel Nicolaus from $36.00 to $54.00 in a research note issued to investors on Tuesday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. Several other analysts have also commented on SYRE. TD Cowen started coverage on Spyre Therapeutics in […]

Stifel-nicolaus
Jefferies-financial-group
Spyre-therapeutics-inc
Spyre-therapeutics
Free-report
Get-free-report
Spyre-therapeutics-daily

Spyre Therapeutics (SYRE) Announces 12M Share Offering by Selling Stockholders

Spyre Therapeutics (SYRE) Announces 12M Share Offering by Selling Stockholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Spyre-therapeutics

Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
Israel
Ukraine
China
Laurie-stelzer
Jeffrey-albers
Markc-mckenna
Colitis-organisation
Research-development-asset
Exchange-commission
Company-seriesa-preferred-stock
Prometheus-biosciences-inc

Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Israel
China
Ukraine
Jeffrey-albers
Laurie-stelzer
Markc-mckenna
Company-seriesa-preferred-stock
Company-board-of-directors
Linkedin
Development-pipeline-overview
Nasdaq

Head to Head Survey: Oncolytics Biotech (NASDAQ:ONCY) versus Spyre Therapeutics (NASDAQ:SYRE)

Oncolytics Biotech (NASDAQ:ONCY – Get Free Report) and Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings. Insider and Institutional Ownership 1.1% of Oncolytics […]

Massachusetts
United-states
Canada
Waltham
Oncolytics-biotech
Merck-kgaa
Oncolytics-biotech-inc
Merck-kga
Aeglea-biotherapeutics-inc
Spyre-therapeutics-inc
Pfizer-inc